切迫性尿失禁の英語

１，２−エタンジオール誘導体またはその塩を含有する切迫性尿失禁の治療薬例文帳に追加

THERAPEUTIC AGENT FOR IMPENDING INCONTINENCE CONTAINING 1,2-ETHANE DIOL DERIVATIVE OR ITS SALT - 特許庁

EP1受容体が関与する疾患、特に過活動膀胱に伴う頻尿・尿意切迫感や尿失禁，膀胱炎，間質性膀胱炎，前立腺炎などの下部尿路疾患の治療薬に用いることができる化合物の提供。例文帳に追加

To provide a compound which can be used as a therapeutic agent for diseases in which an EP1 receptor is involved, particularly lower urinary tract diseases such as pollakiuria or urinary urgency and incontinence associated with overactive bladder, cystitis, interstitial cystitis and prostatitis. - 特許庁

EP1受容体が関与する疾患、特に過活動膀胱に伴う頻尿・尿意切迫感や尿失禁、膀胱炎、間質性膀胱炎、前立腺炎などの下部尿路疾患の治療薬に用いることができる化合物の提供。例文帳に追加

To provide a compound usable as a therapeutic agent for diseases associated with an EP1 receptor, particularly diseases in the lower urinary tract such as pollakiuria-urinary urgency or incontinence of urine accompanied by the overactive bladder, cystitis, interstitial cystitis or prostatitis. - 特許庁

本発明化合物は、良好なEP1受容体拮抗作用を有することから、EP1受容体が関与する疾患、特に過活動膀胱に伴う頻尿・尿意切迫感や尿失禁、膀胱炎、間質性膀胱炎、前立腺炎などの下部尿路疾患の治療薬として有用である。例文帳に追加

Since the compound has the good antagonistic actions on the EP1 receptor, the compound is useful as the therapeutic agent for the diseases associated with the EP1 receptor, particularly the diseases in the lower urinary tract such as the pollakiuria-urinary urgency or incontinence of urine accompanied by the overactive bladder, cystitis, interstitial cystitis or prostatitis. - 特許庁

以上のことからこれらのカルボン酸誘導体またはその塩はEP1受容体が関与する疾患、特に過活動膀胱に伴う頻尿・尿意切迫感や尿失禁，膀胱炎，間質性膀胱炎，前立腺炎などの下部尿路疾患の治療薬に用いることができる例文帳に追加

The carboxylic acid derivative or its salt can be used as a therapeutic agent for diseases in which an EP1 receptor is involved, particularly a lower urinary tract diseases such as pollakiuria or urinary urgency and incontinence associated with overactive bladder, cystitis, interstitial cystitis and prostatitis. - 特許庁

優れたtrkA 受容体阻害作用に基づく、過活動膀胱を含む各種下部尿路疾患に伴う頻尿、尿意切迫感、尿失禁、及び間質性膀胱炎や慢性前立腺炎などの下部尿路疼痛を伴う各種下部尿路疾患、並びに疼痛を伴う各種疾患の治療及び/又は予防剤を提供すること。例文帳に追加

To provide an agent acting based on an excellent action of inhibiting a trkA receptor and used for treating and/or preventing frequent urination, urinary urgency, and urinary incontinence involved in various lower urinary tract diseases including overactive bladder, various lower-urinary-tract-pain-accompanying lower urinary tract diseases such as interstitial cystitis and chronic prostatitis, and various pain-accompanying diseases. - 特許庁

本医薬は、バニロイド受容体（ＶＲ１）アンタゴニストとして優れた活性を有し、ＶＲ１活性に関する病気の予防および治療、特に切迫性尿失禁、膀胱過活動、慢性痛、神経障害痛、術後疼痛、慢性関節リウマチ痛、神経痛、ニューロパチー、痛覚過敏、神経損傷、虚血症、神経変性、脳卒中、失禁および／または炎症性疾患の治療に有用である。例文帳に追加

To provide a medicine having excellent activities as a vanilloid recep tor (VR1) antagonist, and useful for prevention and treatment of a disease associated with VR1 activities, especially treatment of impending incontinence, bladder overactivity, chronic pain, nervous disorder pain, postoperative pain, rheumatoid arthritis pain, neuralgia, neuropathy, hyperpselaphesia, nerve injury, ischemia, neurodegeneration, apoplexy, incontinence and/or inflammatory disease. - 特許庁